Yandan Yao

9.8k citations
77 papers · 7.1k indexed · 3 hit papers · h-index 37

Yandan Yao

72 papers receiving 7.0k citations

Hit Papers

Gasdermin E suppresses tumour gro...1.2k20112026201620214008001.2k

Peers

Yandan Yao
Comparison fields: 5 of 121
  • Cancer Research 2.3k
  • Immunology 1.7k
  • Molecular Biology 4.5k
  • Oncology 1.4k
  • Biomaterials 511
Replace In‐San Kim with:
In‐San Kim South Korea
Bin Zhang China
Ralph D. Sanderson United States
Reinhard Ebner United States
John Hood United States
Michael Ploug Denmark
Jared Gollob United States
Ming Yan China
Barbara Fingleton United States
Rakesh K. Singh United States
Yandan Yao relative to In‐San Kim South Korea In‐San Kim's profile →
Citations per field
00.5×1.5×
In‐San Kim · 1×
Citations per year

Countries citing papers authored by Yandan Yao

Since Specialization
Citations

This map shows the geographic impact of Yandan Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yandan Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yandan Yao more than expected).

Fields of papers citing papers by Yandan Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yandan Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yandan Yao. The network helps show where Yandan Yao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yandan Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yandan Yao Line = papers co-authored together Yandan Yao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20250
4 20251
5 202320
6 20234
7 20223
8 202218
9 202221
10 2020137
11 2019128
12 20185
13 201743
14
A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasisbreakdown →
2015746
15 201466
16 2011125
17 2011100
18 2011110
19 201118
20 2009351

About Yandan Yao

Yandan Yao is a scholar working on Cancer Research, Oncology and Immunology, having authored 77 papers that have together received 7.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (8 papers), Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (8 papers), MicroRNA in disease regulation (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Immune cells in cancer (7 papers). The work is most often cited by research in Cancer Research (2.3k citations), Immunology (1.7k citations) and Molecular Biology (4.5k citations). Yandan Yao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Erwei Song, Herui Yao, Bodu Liu, Chang Gong, Qiang Liu, Lijuan Sun, Judy Lieberman, Jun Wang, Songyin Huang and Shunying Li. Their work appears in journals such as Nature, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026